Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Estradiol-CDS: Began a Phase II U.K. trial.

November 15, 1993 8:00 AM UTC

Pharmos Corp. (PARSD) Product: Estradiol-CDS, drug delivery technology to target estradiol directly to the brain Indication: Treat Alzheimer's disease in women Status: Began a Phase II U.K. trial in 4...